Clinical data | |
---|---|
Trade names | Biopoin, Eporatio |
ATC code |
|
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
PubChem SID | |
DrugBank | |
Chemical and physical data | |
Formula | C815H1317N233O241S5 |
Molar mass | 18396.19 g·mol−1 |
Epoetin theta, sold under the brand name Biopoin among others, is a copy of the human hormone erythropoietin. [1] [2]
The most common side effects include shunt thrombosis (clots that can form in blood vessels of patients on dialysis, a blood clearance technique), headache, hypertension (high blood pressure), hypertensive crisis (sudden, dangerously high blood pressure), skin reactions, arthralgia (joint pain) and influenza (flu)-like illness. [1] Epoetin theta was authorized for medical use in the European Union in October 2009. [1] It is on the World Health Organization's List of Essential Medicines. [3]
Epoetin theta is indicated for the treatment of symptomatic anemia in adults. [1]
attribution contains material copied from Biopoin | European Medicines Agency https://www.ema.europa.eu/en/medicines/human/EPAR/biopoin 2021